Literature DB >> 24325564

Proximal disease extension and related predicting factors in ulcerative proctitis.

Bun Kim1, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon.   

Abstract

OBJECTIVE: Ulcerative colitis usually involves the rectum, may extend in a proximal and continuous fashion to involve varying portions of the bowel. However, the risk factors predictive of proximal extension have yet to be determined. The aim of this study was to evaluate both the natural course of disease and the risk factors influencing the proximal disease extension in ulcerative proctitis.
MATERIAL AND METHODS: We retrospectively analyzed 98 patients with ulcerative proctitis at the time of diagnosis who were regularly followed and underwent sigmoidoscopy or colonoscopy between January 2000 and December 2007.
RESULTS: The mean duration of follow-up was 109.2 ± 49.5 months. A total of 27 (27.6%) patients experienced proximal disease extension. Mayo scores were significantly higher in the extension group compared with patients whose ulcerative proctitis did not extend proximally (p < 0.001). Corticosteroid use at initial diagnosis was also more frequent in the extension group (p = 0.026). In addition, chronic, continuous disease activation within 6 months of the initial diagnosis was significantly higher in the extension group (p < 0.001), as was disease relapse and the number of hospitalizations over the entire follow-up period (p < 0.001 and p = 0.002). According to multivariate analysis, disease extension after the initial diagnosis was associated with chronic disease activation, disease relapse and hospitalization (p = 0.030, p = 0.042 and p = 0.044, respectively).
CONCLUSION: Increased severity of disease upon diagnosis of ulcerative proctitis was associated with a higher probability of proximal disease extension during the follow-up period. Moreover, those with disease extension were more likely to experience relapse and to be hospitalized, indicating poor prognosis.

Entities:  

Mesh:

Year:  2013        PMID: 24325564     DOI: 10.3109/00365521.2013.867360

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  16 in total

1.  Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort.

Authors:  Evelyne Dubois; Annick Moens; Rob Geelen; João Sabino; Marc Ferrante; Séverine Vermeire
Journal:  United European Gastroenterol J       Date:  2020-07-06       Impact factor: 4.623

2.  Clinical Predictors and Natural History of Disease Extension in Patients with Ulcerative Proctitis.

Authors:  Emily Walsh; Young Wha Chah; Samantha M Chin; Paul Lochhead; Vijay Yajnik; Vera Denmark; John J Garber; Hamed Khalili
Journal:  Inflamm Bowel Dis       Date:  2017-11       Impact factor: 5.325

Review 3.  Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies.

Authors:  Magnus Hofrenning Wanderås; Bjørn A Moum; Marte Lie Høivik; Øistein Hovde
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

4.  Factors Predictive of Proximal Disease Extension and Clinical Course of Patients Initially Diagnosed with Ulcerative Proctitis in an IBD Referral Center.

Authors:  Sandro da Costa Ferreira; Lilian Rose Otoboni Aprile; Rogério Serafim Parra; Marley Ribeiro Feitosa; Gleici de Castro da Silva Perdoná; Omar Féres; José Joaquim Ribeiro da Rocha; Luiz Ernesto de Almeida Troncon
Journal:  Turk J Gastroenterol       Date:  2022-04       Impact factor: 1.555

5.  Extensive Disease Subtypes in Adult Patients with Ulcerative Colitis: Non-pancolitis Versus Pancolitis.

Authors:  Dong Suk Shin; Jae Hee Cheon; Yong Eun Park; Yehyun Park; Soo Jung Park; Tae Il Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2018-08-25       Impact factor: 3.199

6.  Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort.

Authors:  Johan Burisch; Ryan Ungaro; Ida Vind; Michelle V Prosberg; Flemming Bendtsen; Jean-Frederic Colombel; Marianne K Vester-Andersen
Journal:  J Crohns Colitis       Date:  2017-10-01       Impact factor: 9.071

7.  First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.

Authors:  Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

8.  The Metabolism of Polysaccharide from Atractylodes macrocephala Koidz and Its Effect on Intestinal Microflora.

Authors:  Ruijun Wang; Guisheng Zhou; Mengyue Wang; Ying Peng; Xiaobo Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-19       Impact factor: 2.629

9.  Risk factors for complications in patients with ulcerative colitis.

Authors:  Christine N Manser; Jan Borovicka; Frank Seibold; Stephan R Vavricka; Peter L Lakatos; Michael Fried; Gerhard Rogler
Journal:  United European Gastroenterol J       Date:  2016-01-19       Impact factor: 4.623

10.  Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission.

Authors:  Jongbeom Shin; Sung Min Kong; Tae Jun Kim; Eun Ran Kim; Sung Noh Hong; Dong Kyung Chang; Young-Ho Kim
Journal:  Gut Liver       Date:  2021-05-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.